Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
Medical Hypotheses|June 3, 2017
Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eyeRohit Bisht, Jagdish K Jaiswal, Ilva D RupenthalPharmaceutics|February 6, 2021
Formulation Considerations for the Management of Dry Eye DiseasePriyanka Agarwal, Jennifer P Craig, Ilva D RupenthalAdvanced Drug Delivery Reviews|September 17, 2017
Overcoming ocular drug delivery barriers through the use of physical forcesDi Huang, Ying-Shan Chen, Ilva D RupenthalMolecular Pharmaceutics|December 21, 2016
Hyaluronic Acid Coated Albumin Nanoparticles for Targeted Peptide Delivery to the RetinaDi Huang, Ying-Shan Chen, Ilva D RupenthalOphthalmic Research|November 23, 2018
Evaluation of 2 ex vivo Bovine Cornea Storage Protocols for Drug Delivery ApplicationsSachin S Thakur, Darshan Shrestha, Ilva D RupenthalInternational Journal of Pharmaceutics|April 2, 2011
Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro releaseIlva D Rupenthal, Colin R Green, Raid G AlanyScientific Reports|July 28, 2018
Intracellular oligonucleotide delivery using the cell penetrating peptide XentryFrazer P Coutinho, Colin R Green, Ilva D RupenthalEuropean Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 13, 2023
Preclinical characterization of water-free cyclosporine eye drops - Factors impacting ocular penetration ex vivo and in vivoPriyanka Agarwal, Johannes Korward, Sonja Krösser, et al.International Journal of Pharmaceutics|April 2, 2011
Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic studyIlva D Rupenthal, Colin R Green, Raid G AlanyPharmaceutical Development and Technology|September 7, 2017
Medicated ocular bandages and corneal health: potential excipients and active pharmaceutical ingredientsGhada Zidan, Ilva D Rupenthal, Carol Greene, et al.Pageof 11